• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于生物安全应用的限制支原体生长的遗传工具包和基因开关。

A genetic toolkit and gene switches to limit Mycoplasma growth for biosafety applications.

机构信息

Department of Life Sciences, Imperial College London, London, SW7 2AZ, UK.

Laboratory of Systems and Synthetic Biology, Wageningen University & Research, Wageningen, the Netherlands.

出版信息

Nat Commun. 2022 Apr 7;13(1):1910. doi: 10.1038/s41467-022-29574-0.

DOI:10.1038/s41467-022-29574-0
PMID:35393441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8991246/
Abstract

Mycoplasmas have exceptionally streamlined genomes and are strongly adapted to their many hosts, which provide them with essential nutrients. Owing to their relative genomic simplicity, Mycoplasmas have been used to develop chassis for biotechnological applications. However, the dearth of robust and precise toolkits for genomic manipulation and tight regulation has hindered any substantial advance. Herein we describe the construction of a robust genetic toolkit for M. pneumoniae, and its successful deployment to engineer synthetic gene switches that control and limit Mycoplasma growth, for biosafety containment applications. We found these synthetic gene circuits to be stable and robust in the long-term, in the context of a minimal cell. With this work, we lay a foundation to develop viable and robust biosafety systems to exploit a synthetic Mycoplasma chassis for live attenuated vectors for therapeutic applications.

摘要

支原体具有极其精简的基因组,并能很好地适应其众多宿主,从宿主那里获取必要的营养。由于其相对简单的基因组,支原体已被用于开发生物技术应用的底盘。然而,缺乏用于基因组操作和严格调控的强大而精确的工具包,阻碍了任何实质性的进展。在此,我们描述了一种用于肺炎支原体的强大遗传工具包的构建,并成功地将其用于设计合成基因开关,以控制和限制支原体生长,用于生物安全控制应用。我们发现,这些合成基因回路在最小细胞环境中具有长期的稳定性和鲁棒性。通过这项工作,我们为开发可行且强大的生物安全系统奠定了基础,以利用合成支原体底盘作为治疗应用的活减毒载体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71d3/8991246/c56efb3e2873/41467_2022_29574_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71d3/8991246/034b19decd5d/41467_2022_29574_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71d3/8991246/c97e8fce07f7/41467_2022_29574_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71d3/8991246/60a67e176888/41467_2022_29574_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71d3/8991246/c56efb3e2873/41467_2022_29574_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71d3/8991246/034b19decd5d/41467_2022_29574_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71d3/8991246/c97e8fce07f7/41467_2022_29574_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71d3/8991246/60a67e176888/41467_2022_29574_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71d3/8991246/c56efb3e2873/41467_2022_29574_Fig4_HTML.jpg

相似文献

1
A genetic toolkit and gene switches to limit Mycoplasma growth for biosafety applications.用于生物安全应用的限制支原体生长的遗传工具包和基因开关。
Nat Commun. 2022 Apr 7;13(1):1910. doi: 10.1038/s41467-022-29574-0.
2
The mechanisms underlying antigenic variation and maintenance of genomic integrity in Mycoplasma pneumoniae and Mycoplasma genitalium.肺炎支原体和生殖支原体抗原变异和基因组完整性维持的机制。
Arch Microbiol. 2021 Mar;203(2):413-429. doi: 10.1007/s00203-020-02041-4. Epub 2020 Sep 24.
3
Genome Editing Based on Oligo Recombineering and Cas9-Mediated Counterselection.基于寡核苷酸重组和 Cas9 介导的反筛选的基因组编辑。
ACS Synth Biol. 2020 Jul 17;9(7):1693-1704. doi: 10.1021/acssynbio.0c00022. Epub 2020 Jun 22.
4
Comparative genomics of mycoplasmas.支原体的比较基因组学
Wien Klin Wochenschr. 1997 Aug 8;109(14-15):551-6.
5
Gene editing tools for mycoplasmas: references and future directions for efficient genome manipulation.用于支原体的基因编辑工具:高效基因组操作的参考文献及未来方向
Front Microbiol. 2023 May 18;14:1191812. doi: 10.3389/fmicb.2023.1191812. eCollection 2023.
6
Auxotrophy to Xeno-DNA: an exploration of combinatorial mechanisms for a high-fidelity biosafety system for synthetic biology applications.对异源DNA的营养缺陷型:探索用于合成生物学应用的高保真生物安全系统的组合机制。
J Biol Eng. 2018 Aug 14;12:13. doi: 10.1186/s13036-018-0105-8. eCollection 2018.
7
Molecular biology and pathogenicity of mycoplasmas.支原体的分子生物学与致病性
Microbiol Mol Biol Rev. 1998 Dec;62(4):1094-156. doi: 10.1128/MMBR.62.4.1094-1156.1998.
8
A RAGE Based Strategy for the Genome Engineering of the Human Respiratory Pathogen .基于 RAGE 的人类呼吸道病原体基因组工程策略。
ACS Synth Biol. 2020 Oct 16;9(10):2737-2748. doi: 10.1021/acssynbio.0c00263. Epub 2020 Oct 5.
9
Cross-hybridization between the cytadhesin genes of Mycoplasma pneumoniae and Mycoplasma genitalium and genomic DNA of Mycoplasma gallisepticum.肺炎支原体与生殖支原体的细胞黏附素基因之间以及鸡毒支原体基因组DNA之间的交叉杂交。
Microb Pathog. 1990 May;8(5):371-5. doi: 10.1016/0882-4010(90)90096-9.
10
Detection and discrimination of Mycoplasma pneumoniae and Mycoplasma genitalium by the in vitro DNA amplification.通过体外DNA扩增检测和鉴别肺炎支原体和生殖支原体。
Microbiol Immunol. 1992;36(1):21-7. doi: 10.1111/j.1348-0421.1992.tb01638.x.

引用本文的文献

1
A genetic safeguard for eliminating target genes in synthetic probiotics in a gut environment.一种用于在肠道环境中消除合成益生菌中靶基因的基因保护措施。
iScience. 2025 Jun 27;28(8):113027. doi: 10.1016/j.isci.2025.113027. eCollection 2025 Aug 15.
2
Robust and highly efficient transformation method for a minimal mycoplasma cell.一种适用于最小支原体细胞的稳健且高效的转化方法。
J Bacteriol. 2025 Mar 20;207(3):e0041524. doi: 10.1128/jb.00415-24. Epub 2025 Feb 4.
3
Bacterial live therapeutics for human diseases.用于人类疾病的细菌活体疗法。

本文引用的文献

1
Engineering a genome-reduced bacterium to eliminate Staphylococcus aureus biofilms in vivo.工程化基因组减缩细菌以消除体内金黄色葡萄球菌生物膜。
Mol Syst Biol. 2021 Oct;17(10):e10145. doi: 10.15252/msb.202010145.
2
Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs.猪支原体肺炎疫苗改进的前景。
Vet Res. 2021 May 8;52(1):67. doi: 10.1186/s13567-021-00941-x.
3
Model-driven design allows growth of Mycoplasma pneumoniae on serum-free media.模型驱动设计允许肺炎支原体在无血清培养基中生长。
Mol Syst Biol. 2024 Dec;20(12):1261-1281. doi: 10.1038/s44320-024-00067-0. Epub 2024 Oct 23.
4
Engineering bacterial theranostics: from logic gates to applications.工程化细菌诊疗学:从逻辑门到应用
Front Bioeng Biotechnol. 2024 Sep 18;12:1437301. doi: 10.3389/fbioe.2024.1437301. eCollection 2024.
5
Engineering stringent genetic biocontainment of yeast with a protein stability switch.利用蛋白质稳定性开关对酵母进行严格的基因生物遏制工程。
Nat Commun. 2024 Feb 5;15(1):1060. doi: 10.1038/s41467-024-44988-8.
6
Mammalian cell growth characterisation by a non-invasive plate reader assay.利用非侵入式平板读数仪分析哺乳动物细胞的生长特性。
Nat Commun. 2024 Jan 2;15(1):57. doi: 10.1038/s41467-023-44396-4.
7
Gene editing tools for mycoplasmas: references and future directions for efficient genome manipulation.用于支原体的基因编辑工具:高效基因组操作的参考文献及未来方向
Front Microbiol. 2023 May 18;14:1191812. doi: 10.3389/fmicb.2023.1191812. eCollection 2023.
8
Safety by design: Biosafety and biosecurity in the age of synthetic genomics.设计中的安全:合成基因组学时代的生物安全与生物安保。
iScience. 2023 Feb 10;26(3):106165. doi: 10.1016/j.isci.2023.106165. eCollection 2023 Mar 17.
9
Bacterial expression of a designed single-chain IL-10 prevents severe lung inflammation.设计的单链 IL-10 的细菌表达可预防严重的肺部炎症。
Mol Syst Biol. 2023 Jan;19(1):e11037. doi: 10.15252/msb.202211037. Epub 2023 Jan 4.
NPJ Syst Biol Appl. 2020 Oct 23;6(1):33. doi: 10.1038/s41540-020-00153-7.
4
A RAGE Based Strategy for the Genome Engineering of the Human Respiratory Pathogen .基于 RAGE 的人类呼吸道病原体基因组工程策略。
ACS Synth Biol. 2020 Oct 16;9(10):2737-2748. doi: 10.1021/acssynbio.0c00263. Epub 2020 Oct 5.
5
Current status of vaccine research, development, and challenges of vaccines for Mycoplasma gallisepticum.鸡毒支原体疫苗的研究、开发现状及面临的挑战
Poult Sci. 2020 Sep;99(9):4195-4202. doi: 10.1016/j.psj.2020.06.014. Epub 2020 Jun 27.
6
Genome Editing Based on Oligo Recombineering and Cas9-Mediated Counterselection.基于寡核苷酸重组和 Cas9 介导的反筛选的基因组编辑。
ACS Synth Biol. 2020 Jul 17;9(7):1693-1704. doi: 10.1021/acssynbio.0c00022. Epub 2020 Jun 22.
7
Inferring Active Metabolic Pathways from Proteomics and Essentiality Data.从蛋白质组学和必需性数据推断活跃的代谢途径。
Cell Rep. 2020 Jun 2;31(9):107722. doi: 10.1016/j.celrep.2020.107722.
8
Developing a new class of engineered live bacterial therapeutics to treat human diseases.开发一类新型工程活菌疗法药物,用于治疗人类疾病。
Nat Commun. 2020 Apr 8;11(1):1738. doi: 10.1038/s41467-020-15508-1.
9
CReasPy-Cloning: A Method for Simultaneous Cloning and Engineering of Megabase-Sized Genomes in Yeast Using the CRISPR-Cas9 System.CReasPy克隆:一种使用CRISPR-Cas9系统在酵母中同时克隆和改造兆碱基大小基因组的方法。
ACS Synth Biol. 2019 Nov 15;8(11):2547-2557. doi: 10.1021/acssynbio.9b00224. Epub 2019 Oct 30.
10
Determination of the Gene Regulatory Network of a Genome-Reduced Bacterium Highlights Alternative Regulation Independent of Transcription Factors.确定基因组简化细菌的基因调控网络突出了转录因子独立的替代调控。
Cell Syst. 2019 Aug 28;9(2):143-158.e13. doi: 10.1016/j.cels.2019.07.001. Epub 2019 Aug 21.